Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CCR1 | P32246 | 3/20 | 0.43 |
| ▸ | CCR5 | P51681 | 3/20 | 0.43 |
| ▸ | CCR8 | P51685 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | METAP1 | P53582 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.43 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.43 |
| ▸ | ULK1 | O75385 | 1/20 | 0.39 |
| ▸ | CDK7 | P50613 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.39 |
| ▸ | CAMK2G | Q13555 | 1/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.39 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.39 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2139205 | 0.84 | KDM4E (0.45) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL28853259 | 0.81 | KDM4E (0.49) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL9715965 | 0.80 | KDM4E (0.48) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL12470406 | 0.76 | KDM4E (0.43) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL29144642 | 0.73 | KDM4E (0.41) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL6769901 | 0.71 | KDM4E (0.50) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL176039 | 0.70 | KDM4E (0.68) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL6412157 | 0.67 | GRM5 (0.32) | — | |
| SCHEMBL29003 | 0.66 | TDP1 (0.39) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL2507724 | 0.66 | KDM4E (0.54) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117186365-A | Metallized conjugated microporous polymer based on carbazole derivative and pyridine derivative, and preparation method and application thereof | 浙江工业大学 | 2023-12-08 | — | — | CN | disclosed |
| US-20180214827-A1 | PERYLENE DIIMIDE BASED MEMBRANE AND METHODS OF USE THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-08-02 | — | — | US | disclosed |
| EP-3319715-A1 | PERYLENE DIIMIDE BASED MEMBRANE AND METHODS OF USE THEREOF | Yeda Research and Development Co., Ltd. (IL) | 2018-05-16 | — | — | EP | disclosed |
| EP-3067354-B1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | YEDA RES & DEV (IL) | 2018-01-03 | — | — | EP | disclosed |
| US-9701784-B2 | Supramolecular polymers derived from perylene-diimides | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-07-11 | — | — | US | disclosed |
| US-9623381-B2 | Separation of nanoparticles | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-04-18 | — | — | US | disclosed |
| WO-2017006325-A1 | PERYLENE DIIMIDE BASED MEMBRANE AND METHODS OF USE THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-01-12 | — | — | WO | disclosed |
| EP-3112013-A1 | PERYLENE DIIMDE BASED MEMBRANE, PREPARATION AND RECYCLING THEREOF, AND USE FOR NANOPARTICLE SEPARATION THEREOF | Yeda Research and Development Co. Ltd (IL) | 2017-01-04 | — | — | EP | disclosed |
| EP-3067354-A1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | Yeda Research and Development Co. Ltd. (IL) | 2016-09-14 | — | — | EP | disclosed |
| US-20150375180-A1 | SEPARATION OF NANOPARTICLES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2015-12-31 | — | — | US | disclosed |
| US-20150240027-A1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2015-08-27 | — | — | US | disclosed |
| US-9067181-B2 | Separation of nanoparticles | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (US) | 2015-06-30 | — | — | US | disclosed |
| US-8968886-B2 | Doubly reduced perylene-diimides and supramolecular polymers derived from perylene-diimides | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2015-03-03 | — | — | US | disclosed |
| US-20130303769-A1 | SEPARATION OF NANOPARTICLES | YEDA RESEARCH AND DEVELOPMENT CO. LTD (IL) | 2013-11-14 | — | — | US | disclosed |
| EP-2608874-A1 | SEPARATION OF NANOPARTICLES | Yeda Research and Development Co. Ltd. (IL) | 2013-07-03 | — | — | EP | disclosed |
| WO-2012025928-A1 | SEPARATION OF NANOPARTICLES | YEDA RESEARCH AND DEVELOPMENT CO.LTD (IL) | 2012-03-01 | — | — | WO | disclosed |
| US-20110101276-A1 | DOUBLY REDUCED PERYLENE-DIIMIDES AND SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | YEDA RESEARCH AND DEVELOPMENT CO.LTD (IL) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150240027-A1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | PIN1, PARN, DDT | KDM4E 2710/4885LMNA 1103/4885CCR1 2945/4885 |
| US-20150375180-A1 | SEPARATION OF NANOPARTICLES | NCL, CD63, PARN | KDM4E 1712/4885LMNA 620/4885CCR1 4535/4885 |
| US-20110101276-A1 | DOUBLY REDUCED PERYLENE-DIIMIDES AND SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | NR2E3, NR2C2, NR0B2 | KDM4E 2335/4885LMNA 2117/4885CCR1 1840/4885 |
| US-20130303769-A1 | SEPARATION OF NANOPARTICLES | NCL, CD63, PARN | KDM4E 1712/4885LMNA 620/4885CCR1 4535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.